Sale!

TRIP11 Gene Achondrogenesis Type 1A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRIP11 gene Achondrogenesis Type 1A genetic test is a specialized diagnostic procedure designed to identify mutations in the TRIP11 gene, which are responsible for Achondrogenesis Type 1A, a rare and severe genetic disorder affecting skeletal development. This condition is characterized by a significant lack of bone formation, leading to extremely short limbs, a small chest, and other skeletal abnormalities that are usually fatal before or shortly after birth.

The test involves analyzing the patient’s DNA to detect any mutations in the TRIP11 gene that are indicative of Achondrogenesis Type 1A. This is crucial for accurate diagnosis, guiding treatment plans, and offering genetic counseling to affected families.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures precision and reliability, employing state-of-the-art technology to analyze genetic material. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results accurately.

For families with a history of genetic disorders or those experiencing relevant symptoms, this test provides essential insights into the genetic factors influencing their health, enabling informed decisions about care and management.

Description

TRIP11 Gene Achondrogenesis type 1A Genetic Test

Test Name: TRIP11 Gene Achondrogenesis type 1A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TRIP11 Gene Achondrogenesis type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRIP11 Gene Achondrogenesis type 1A NGS Genetic DNA Test gene TRIP11

Test Details: The TRIP11 gene is associated with a rare genetic disorder called achondrogenesis type 1A. This disorder affects bone growth and development, leading to severe skeletal abnormalities and short stature. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA sequence. In the context of achondrogenesis type 1A, NGS genetic testing can be used to identify mutations or variations in the TRIP11 gene that may be responsible for the disorder. By analyzing the DNA sequence of the TRIP11 gene, NGS genetic testing can provide information about specific mutations or variations that may be causing achondrogenesis type 1A in an individual. This information can be useful for diagnosis, genetic counseling, and potentially guiding treatment options or management strategies for affected individuals.

Test Name	TRIP11 Gene Achondrogenesis type 1A Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TRIP11 Gene Achondrogenesis type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRIP11 Gene Achondrogenesis type 1A NGS Genetic DNA Test gene TRIP11
Test Details	The TRIP11 gene is associated with a rare genetic disorder called achondrogenesis type 1A. This disorder affects bone growth and development, leading to severe skeletal abnormalities and short stature. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA sequence. In the context of achondrogenesis type 1A, NGS genetic testing can be used to identify mutations or variations in the TRIP11 gene that may be responsible for the disorder. By analyzing the DNA sequence of the TRIP11 gene, NGS genetic testing can provide information about specific mutations or variations that may be causing achondrogenesis type 1A in an individual. This information can be useful for diagnosis, genetic counseling, and potentially guiding treatment options or management strategies for affected individuals.